1. Home
  2. EVGN vs POAI Comparison

EVGN vs POAI Comparison

Compare EVGN & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • POAI
  • Stock Information
  • Founded
  • EVGN 1999
  • POAI 2002
  • Country
  • EVGN Israel
  • POAI United States
  • Employees
  • EVGN N/A
  • POAI N/A
  • Industry
  • EVGN Agricultural Chemicals
  • POAI Industrial Specialties
  • Sector
  • EVGN Industrials
  • POAI Health Care
  • Exchange
  • EVGN Nasdaq
  • POAI Nasdaq
  • Market Cap
  • EVGN 9.7M
  • POAI 8.9M
  • IPO Year
  • EVGN N/A
  • POAI N/A
  • Fundamental
  • Price
  • EVGN $1.09
  • POAI $0.88
  • Analyst Decision
  • EVGN Strong Buy
  • POAI Hold
  • Analyst Count
  • EVGN 1
  • POAI 1
  • Target Price
  • EVGN $3.50
  • POAI N/A
  • AVG Volume (30 Days)
  • EVGN 47.1K
  • POAI 230.8K
  • Earning Date
  • EVGN 05-21-2025
  • POAI 05-15-2025
  • Dividend Yield
  • EVGN N/A
  • POAI N/A
  • EPS Growth
  • EVGN N/A
  • POAI N/A
  • EPS
  • EVGN N/A
  • POAI N/A
  • Revenue
  • EVGN $6,765,000.00
  • POAI $1,729,269.00
  • Revenue This Year
  • EVGN $68.62
  • POAI $486.27
  • Revenue Next Year
  • EVGN $66.92
  • POAI $65.50
  • P/E Ratio
  • EVGN N/A
  • POAI N/A
  • Revenue Growth
  • EVGN N/A
  • POAI 24.17
  • 52 Week Low
  • EVGN $0.95
  • POAI $0.55
  • 52 Week High
  • EVGN $7.75
  • POAI $3.06
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 40.78
  • POAI 36.28
  • Support Level
  • EVGN $1.08
  • POAI $0.87
  • Resistance Level
  • EVGN $1.43
  • POAI $0.97
  • Average True Range (ATR)
  • EVGN 0.08
  • POAI 0.08
  • MACD
  • EVGN -0.01
  • POAI -0.02
  • Stochastic Oscillator
  • EVGN 8.11
  • POAI 4.65

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: